Tirzepatide is a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://hamzaogpe154854.blogolize.com/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist-79688002